No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
DYAI Dyadic
- 1.480
- +0.030+2.07%
Close Jul 3 13:00 ET
- 1.560
- +0.080+5.41%
Post 15:54 ET
43.27MMarket Cap-5285P/E (TTM)
1.590High1.450Low59.15KVolume1.450Open1.450Pre Close90.86KTurnover0.32%Turnover RatioLossP/E (Static)29.24MShares2.67052wk High9.61P/B27.73MFloat Cap1.19052wk Low--Dividend TTM18.74MShs Float10.980Historical High--Div YieldTTM9.66%Amplitude1.120Historical Low1.536Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Dyadic International Strikes Major Biotech Deal With Proliant
Dyadic International Secures Lucrative Biotech Licensing Deal
Express News | Watching Dyadic International; Zacks Small-Cap Research Gives Stock $9 Price Valuation
Dyadic Dips on New Partnership With Proliant
Dyadic International, Inc. and Proliant Health and Biologicals Announce Recombinant Albumin Development and Commercialization Partnership
JUPITER, Fla., June 28, 2024 — Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health
Form 144 | Dyadic(DYAI.US) 10% Stockholder Proposes to Sell 657.9K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 6, $Dyadic(DYAI.US)$ 10% Stockholder Francisco Trust under agreement dated February 28, 1996 intends to sell 292.4K shares of its common stock on Jun 6, with a total market
Comments
Doug Pace's appointment is a positive step for Dyadic's expansion in business development across core verticals. His biopharmaceutical expertise would facilitate Dyadic's leverage on C1 and Dapibus platforms to tap into the growing preventative, therapeutic biologic and alternative protein markets.
Press Release: Dyadic Appoints Doug Pace to Its Executive Leadership Team
$DYAI — STOCK & OPTION PLAY
NEED IT TO BREAK OVER: $5.23
key indicator for MORE uptrend $5.50
confirmation uptrend - $5.76
mini breakout - $5.83
full breakout - $5.98
SEMI PARABOLIC - $6.09
stop loss — $4.57
& support - $3.94. $Dyadic(DYAI.US$
NEED IT TO BREAK OVER: $5.23
key indicator for MORE uptrend $5.50
confirmation uptrend - $5.76
mini breakout - $5.83
full breakout - $5.98
SEMI PARABOLIC - $6.09
stop loss — $4.57
& support - $3.94. $Dyadic(DYAI.US$
2
$DYAI — STOCK & OPTION PLAY
NEED IT TO BREAK OVER: $5.50
key indicator for MORE uptrend $5.76
confirmation uptrend - $5.83
mini breakout - $5.98
full breakout - $6.09
SEMI PARABOLIC - $6.79
stop loss — $4.87
& support - $4.31. $Dyadic(DYAI.US$
NEED IT TO BREAK OVER: $5.50
key indicator for MORE uptrend $5.76
confirmation uptrend - $5.83
mini breakout - $5.98
full breakout - $6.09
SEMI PARABOLIC - $6.79
stop loss — $4.87
& support - $4.31. $Dyadic(DYAI.US$
1
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg